{
    "id": 16254,
    "fullName": "JUN positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "JUN positive indicates the presence of the JUN gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 3725,
        "geneSymbol": "JUN",
        "terms": [
            "JUN",
            "AP-1",
            "AP1",
            "c-Jun",
            "cJUN",
            "p39"
        ]
    },
    "variant": "positive",
    "createDate": "01/07/2016",
    "updateDate": "05/27/2016",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 3853,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, Dz13 demonstrated safety, reduced tumor c-Jun expression, and showed some preliminary efficacy in patients with nodular basal cell carcinoma (PMID: 23660123).",
            "molecularProfile": {
                "id": 16528,
                "profileName": "JUN positive"
            },
            "therapy": {
                "id": 3371,
                "therapyName": "Dz13",
                "synonyms": null
            },
            "indication": {
                "id": 4280,
                "name": "nodular basal cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 4239,
                    "pubMedId": 23660123,
                    "title": "Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23660123"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 16528,
            "profileName": "JUN positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}